TY - CONF
T1 - Cost effectiveness of adalimumab therapy vs. conventional care in the United Kingdom (UK) patients with active ankylosing spondylitis (AS)
JO - ANNALS OF THE RHEUMATIC DISEASES
PY - 2006/07/01
AU - Botteman MF
AU - Hay JW
AU - Van Hout BA
AU - Curry A
AU - Wong R
AU - Luo MP
ED -
VL - 65
SP - 207
EP - 208
Y2 - 2025/07/14
ER -